![]() |
市場調查報告書
商品編碼
2041622
雙能和多能CT市場預測至2034年-按產品類型、類型、應用、最終用戶和地區分類的全球分析Dual And Multi Energy Computed Tomography Market Forecasts to 2034 - Global Analysis By Product, Type, Application, End User,and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球雙能和多能 CT 市場規模將達到 21 億美元,並在預測期內以 10.2% 的複合年成長率成長,到 2034 年將達到 46 億美元。
雙能和多能CT(電腦斷層掃描)是先進的成像技術,與傳統的單能電腦斷層掃描相比,具有更優異的診斷能力。這些技術可同時擷取不同能量水平的多組影像,進而提高組織表徵的準確性和診斷精度。雙能和多能CT的全球應用正在拓展醫學影像的範圍,為臨床醫生提供關於組織成分的寶貴信息,並增強診斷信心。
根據美國國立衛生研究院(NIH)的數據,65歲及以上的患者接受的影像影像檢查次數是年輕患者的兩倍以上。此外,女性通常比男性需要接受更多的影像檢查。
提高意識和教育
醫療專業人員和機構對雙重能量和多能量CT的功能和優勢有了更深入的了解,因此對這些先進成像技術的興趣日益濃厚,並更願意將其應用於臨床實踐。此外,教育活動、培訓計畫和知識傳播工作也有助於人們更好地理解雙能量和多能量CT的診斷優勢,從而推動市場擴張。
高成本
這些系統高度複雜,需要複雜的硬體和軟體組件,因此成本高昂。對醫療機構而言,尤其是在資源匱乏的環境中,高成本可能構成巨大的經濟負擔。此外,這些系統的持續維護、升級和保養也需要投入大量資金。因此,患者在取得先進成像技術可能面臨不平等,進而影響患者的治療效果,最終阻礙市場成長。
技術進步
影像處理能力和診斷準確性方面取得了顯著進展。這些進步使得組織表徵更加便捷,雙能和多能CT在區分不同組織類型和檢測細微異常方面特別有效。此外,人工智慧(AI)與雙能和多能CT系統的整合正在革新診斷工作流程,從而推動市場成長。
缺乏標準化
缺乏標準化是指影像擷取方案和資料分析方法缺乏統一性和一致性。這給數據解讀、結果比較以及不同系統和機構間的資訊交流帶來了挑戰。此外,採集和重建參數缺乏標準化方案,也影響了影像品質和診斷準確性的一致性。這阻礙了雙能和多能CT掃描儀臨床應用合作研究指南的發展。
新冠疫情的影響
新冠疫情對市場造成了多方面的負面影響。為應對疫情而轉移的醫療資源和優先事項減緩了對先進成像技術的投資和應用。此外,疫情擾亂了醫療設備的供應鏈,導致生產、運輸和安裝延誤,進而阻礙了市場成長。
在預測期內,高速千伏開關(kVp)領域預計將佔據最大佔有率。
高速千伏(kVp)切換(kVp)技術預計將佔據最大市場佔有率,在提升成像能力方面發揮至關重要的作用。此技術可在影像擷取過程中快速改變X光管的電壓,從而實現近乎同時產生多個能量等級。此外,在不同能量水平下採集影像的能力提高了對比度解析度,並為各種臨床應用提供了寶貴的信息,進而推動了該領域的成長。
在預測期內,回顧性分析領域預計將呈現最高的複合年成長率。
預計回顧性影像細分市場在預測期內將呈現最高的複合年成長率,因為它採用影像重建方法,使醫療專業人員能夠分析和處理初始掃描後所獲取的影像。此外,雙重能量和多能量CT的回顧性功能提高了醫療服務提供者在診斷過程中做出明智決策的能力,從而惠及醫療機構,推動了該細分市場的成長。
在預測期內,亞太地區佔據了最大的市場佔有率,這主要得益於慢性病盛行率的上升、健康意識的增強以及醫療技術的進步。中國、日本、印度和韓國等國家對先進診斷工具的需求不斷成長,以應對老化醫療保健挑戰和日益加重的疾病負擔。此外,研發活動的激增和本土醫療技術公司的蓬勃發展也推動了市場成長。
預計在預測期內,歐洲將錄得最高的複合年成長率,這主要得益於對提高診斷準確性和增強解剖結構可視化效果的重視,以及對最先進的雙能和多能CT掃描儀的投資需求。人工智慧(AI)與雙能和多能CT系統的整合進一步提升了診斷能力。此外,歐洲的監管措施和標準正在促進這些技術的安全有效部署,從而推動區域成長。
According to Stratistics MRC, the Global Dual and Multi Energy Computed Tomography Market is accounted for $2.1 billion in 2026 and is expected to reach $4.6 billion by 2034 growing at a CAGR of 10.2% during the forecast period. Dual and multi-energy computed tomography (CT) are advanced imaging techniques that provide enhanced diagnostic capabilities compared to traditional single-energy CT scans. These technologies involve the simultaneous acquisition of multiple sets of images at different energy levels, allowing for improved tissue characterization and diagnostic accuracy. The global application of dual and multi-energy CT has broadened the scope of medical imaging, offering clinicians' valuable insights into tissue composition and improving diagnostic confidence.
According to data of the National Institutes of Health, patients age 65 and older undergo diagnostic imaging two or more times than that of younger people. Women also tend to need imaging slightly more than men.
Increased awareness and education
Healthcare professionals and institutions become more informed about the capabilities and benefits of dual and multi-energy CT, leading to a heightened interest and inclination to incorporate these advanced imaging technologies into clinical practice. Furthermore, educational initiatives, training programs, and knowledge dissemination efforts contribute to a better understanding of the diagnostic advantages offered by dual and multi-energy CT, which are propelling this market expansion.
High cost
The sophisticated nature of these systems involves complex hardware and software components, which contributes to their high cost. This high cost can pose a financial challenge for healthcare providers, particularly in resource-constrained settings. Additionally, the ongoing maintenance, upgrades, and servicing of these systems can be expensive. This can result in a disparity in access to advanced imaging technology, potentially impacting patient care and outcomes, which is impeding market growth.
Technological advancements
There has been substantial progress in enhancing imaging capabilities and diagnostic accuracy. These advancements facilitate better tissue characterization, making dual and multi-energy CT particularly valuable for differentiating between various types of tissues and detecting subtle abnormalities. Moreover, the integration of artificial intelligence (AI) into dual and multi-energy CT systems has revolutionized diagnostic workflows, which drives this market size.
Lack of standardization
The lack of standardization refers to the absence of uniformity and consistency in terms of imaging protocols and data analysis techniques, which pose challenges in data interpretation, comparison of results, and the exchange of information between different systems and institutions. Moreover, the absence of standardized protocols for acquisition and reconstruction parameters hampers consistency in image quality and diagnostic accuracy. This hinders collaboration and research guidelines for the clinical use of dual and multi-energy CT scanners.
Covid-19 Impact
The COVID-19 pandemic has had several negative impacts on the market. The diversion of healthcare resources and priorities towards managing the pandemic has slowed down investments and the adoption of advanced imaging technologies. Moreover, the pandemic has disrupted the supply chain for medical equipment, leading to delays in manufacturing, shipping, and installation, which have thereby hampered market growth.
The rapid kilovoltage switching (kVp) segment is expected to be the largest during the forecast period
The rapid kilovoltage switching (kVp) segment is estimated to hold the largest share due to its pivotal role in enhancing imaging capabilities. This technology involves the rapid alteration of X-ray tube voltage during image acquisition, allowing for the generation of multiple energy levels almost simultaneously. Furthermore, the ability to acquire images at different energy levels enhances contrast resolution and provides valuable information for various clinical applications, which is propelling this segment's growth.
The retrospective segment is expected to have the highest CAGR during the forecast period
The retrospective segment is anticipated to have highest CAGR during the forecast period due to a mode of image reconstruction that allows healthcare professionals to retrospectively analyze and manipulate acquired images after the initial scan. Moreover, healthcare providers benefit from the retrospective capabilities of dual and multi-energy CT as it enhances their ability to make informed decisions during the diagnostic process, which is boosting this segment's expansion.
Asia Pacific commanded the largest market share during the extrapolated period owing to the increasing prevalence of chronic diseases, rising healthcare awareness, and advancements in medical technology. In countries like China, Japan, India, and South Korea, there is a growing demand for advanced diagnostic tools to address the healthcare challenges associated with an aging population and the increasing burden of diseases. In addition, the market is driven by a surge in research and development activities, and local medical technology firms.
Europe is expected to witness highest CAGR over the projection period, owing to the emphasis on improved diagnostic accuracy and enhanced visualization of anatomical structures and the need to invest in state-of-the-art dual and multi-energy CT scanners. The integration of artificial intelligence (AI) into dual and multi-energy CT systems has further strengthened diagnostic capabilities. Moreover, regulatory initiatives and standards in Europe have been conducive to ensuring the safe and effective implementation of these technologies, which is boosting regional growth.
Key players in the market
Some of the key players in the Dual and Multi Energy Computed Tomography Market include Koninklijke Philips N.V., Stryker Corp., GE Healthcare, Hitachi Healthcare Systems, Fujifilm Holdings Corp, Canon Medical Systems, Koning Corp., Shimadzu Corp., Neusoft Medical Systems Co. Ltd., CareStream Health and Planmeca Group.
In November 2023, Canon Inc. and Cleveland Clinic have announced intentions to form a strategic research partnership to develop innovative imaging and healthcare IT technologies aimed at improving diagnosis, care and outcomes for patients.
In July 2023, Hitachi, Ltd. announced that it has entered a strategic framework collaboration agreement with the world-renowned medical research institution, Brigham and Women's Hospital (BWH), to establish a joint site for "co-creation" to accelerate efforts in gene and cell therapy (GCT) to conquer intractable diseases and realize practical applications.
In January 2023, GE HealthCare announced it has entered into an agreement to acquire MIM Software, a global provider of medical imaging analysis and artificial intelligence (AI) solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology at imaging centers, hospitals, specialty clinics, and research organizations worldwide.